InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026)
InfuSystem Holdings (INFU) posted Asset Writedowns and Impairment of $202000.0 for Q1 2026, down 51.56% on a QoQ basis from $417000.0 in Q4 2025, and down 21.4% year-over-year from $257000.0 in Q1 2025.
InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Asset Writedowns and Impairment history runs 11 years deep, the most recent figure standing at $202000.0 for Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 21.4% year-over-year to $202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464000.0 (up 110.91% YoY) and the FY2025 annual result came in at $519000.0, up 410.78% from the prior year.
- Asset Writedowns and Impairment was $202000.0 for Q1 2026 at InfuSystem Holdings, down from $417000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $450000.0 in Q1 2023 and bottomed at -$845000.0 in Q4 2024.
- A 5-year average of $90058.8 and a median of $171000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment slumped 1000.0% — and 2024, when it surged 765.67%.
- InfuSystem Holdings' Asset Writedowns and Impairment stood at $171000.0 in 2022, then surged by 161.99% to $448000.0 in 2023, then sank by 288.62% to -$845000.0 in 2024, then jumped by 149.35% to $417000.0 in 2025, then tumbled by 51.56% to $202000.0 in 2026.
- Business Quant data shows INFU's Asset Writedowns and Impairment at $202000.0 in Q1 2026, $417000.0 in Q4 2025, and $63000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | InfuSystem Holdings | 189.28 Mn | 187.17 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 417,000.00 |
| Dec 31, 2025 | 417,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -218,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Dec 31, 2023 | 448,000.00 |
| Dec 31, 2023 | 448,000.00 |